Xcout IntelAnodyne Nanotech, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Anodyne Nanotech, Inc. among drug delivery companies — ranked by similarity to what Anodyne Nanotech, Inc. actually does, not by market-cap band.
Subscribe to see Anodyne Nanotech, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. is a Boston, Massachusetts-based clinical-stage biotechnology research company specializing in chronic care through transdermal delivery systems like GLP-1 patches.
Anodyne Nanotech, Inc. at a glance
Anodyne Nanotech, Inc. is a drug delivery company headquartered in United States. Its most recent funding round, Early VC, raised $12.6M in June 2026. Xcout tracks 5 named people at Anodyne Nanotech, Inc., including KONSTANTINOS TZORTZAKIS (Executive Officer).
Anodyne Nanotech, Inc. leadership
- KONSTANTINOS TZORTZAKISExecutive Officer
- LOMBARDO JAKEExecutive Officer
- Georgios PapastergiouDirector
- Michael SingerDirector
- Vikram LambaDirector
Anodyne Nanotech, Inc. funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Early VC | $12.6M | — | |
| Seed | $2.3M | 5 named | |
| SEC Form D filing | $2M | — | |
| SEC Form D filing | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Anodyne Nanotech, Inc. competitors
Ranked by semantic similarity — how close each company is to Anodyne Nanotech, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Drug Discovery
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Drug Discovery
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Drug Discovery
Glycomine, Inc. is a biotherapeutics company focused on developing replacement therapies and treatments for serious rare genetic diseases, operating out of major life science hubs in San Francisco and Boston.
Drug Discovery
Arsenal Medical, Inc. is a biotechnology company headquartered in Watertown and Waltham, Massachusetts, focused on developing advanced medical devices and solutions.
Biopharmaceuticals
Intarcia Therapeutics, Inc. is a biopharmaceutical research company headquartered in Boston, Massachusetts, focused on developing treatments in various therapeutic areas.
Recycling
MacroCycle Technologies Inc. is a technology company with its corporate office located in Cambridge, Massachusetts. The firm is engaged in advanced technology research and development activities.
Climate
Anthology Biotechnologies is a biotechnology research and development company headquartered in Cambridge, Massachusetts, with a European branch in Copenhagen. The company operates in the biotechnology sector, focusing on scientific research and development.
Biopharmaceutical
Belenos Biosciences is a privately held biotechnology research company headquartered in New York, NY. Founded by a team of industry veterans, the firm focuses on discovering and developing therapeutics for chronic inflammatory diseases. They advance drug candidates through various preclinical and clinical development stages.
Biopharmaceuticals
CAGE Bio is a clinical-stage biotechnology company that develops localized therapies for dermatology, inflammation, and immunology. The company utilizes a proprietary deep eutectic ionic liquid platform to enable the skin penetration of small and large molecules, providing topical treatments designed to avoid the side effects of systemic drug exposure.
Synthetically-Derived Cannabinoid
Nalu Bio, Inc. is a San Francisco, California-based biotechnology company that produces chemistry-based cannabinoids designed to treat inflammatory, immune, and metabolic diseases.
Biopharmaceuticals
Amolyt Pharma is a clinical-stage biotechnology company specializing in the development of therapeutic peptides for rare endocrine diseases. Acquired by AstraZeneca, the company focuses on advancing innovative treatments through clinical trials.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Anodyne Nanotech, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Anodyne Nanotech, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →